Free Trial
TSE:CMED

CanniMed Therapeutics (CMED) Stock Price, News & Analysis

CanniMed Therapeutics logo

About CanniMed Therapeutics Stock (TSE:CMED)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
52,208 shs
Average Volume
387,394 shs
Market Capitalization
C$668.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CanniMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CMED Stock News Headlines

ALDX Aldeyra Therapeutics, Inc.
CanniMed Therapeutics Inc (CMED)
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

CMED Stock Analysis - Frequently Asked Questions

Shares of CMED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that CanniMed Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Smith & Nephew (SNN), CannTrust (CTST), Hydropothecary (THCX), CannaRoyalty (CNNRF) and Cronos Group (CRON).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Electronic Computer Manufacturing
Sub-Industry
Cannabis
Current Symbol
TSE:CMED
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$668.44 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (TSE:CMED) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners